Evidence map›Paper›PMID 31528222›Full record

ArticleJournal of Cancer2019

Searching HPV genome for methylation sites involved in molecular progression to cervical precancer.

Christine Kottaridi, Danai Leventakou, Abraham Pouliakis, Vasileios Pergialiotis, George Chrelias, Eugenia Patsouri, Andriani Zacharatou, Eleni Panopoulou, Vasileia Damaskou, Vasileios Sioulas and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of Cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. The Role of p16/Ki67 Dual Staining in Cervical Cancer Screening.Current issues in molecular biology · 2023
    Review
  4. Article
  5. Effects of CpG sites methylation modification of HPV16 integration essential gene on the proliferation of cervical cancer cells.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Article
  6. Epigenetic approaches for cervical neoplasia screening (Review).Experimental and therapeutic medicine · 2021
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Christine Kottaridi2 nd Department of Pathology, University General Hospital "ATTIKON", School of Medicine, National and Kapodistrian University of Athens, Athens 12464, Greece.
Danai Leventakou2 nd Department of Pathology, University General Hospital "ATTIKON", School of Medicine, National and Kapodistrian University of Athens, Athens 12464, Greece.
Abraham Pouliakis2 nd Department of Pathology, University General Hospital "ATTIKON", School of Medicine, National and Kapodistrian University of Athens, Athens 12464, Greece.
Vasileios Pergialiotis3 rd Department of Gynaecology and Obstetrics, University General Hospital "ATTIKON", School of Medicine, National and Kapodistrian University of Athens, Athens 12464, Greece.
George Chrelias3 rd Department of Gynaecology and Obstetrics, University General Hospital "ATTIKON", School of Medicine, National and Kapodistrian University of Athens, Athens 12464, Greece.
Eugenia Patsouri2 nd Department of Pathology, University General Hospital "ATTIKON", School of Medicine, National and Kapodistrian University of Athens, Athens 12464, Greece.
Andriani Zacharatou2 nd Department of Pathology, University General Hospital "ATTIKON", School of Medicine, National and Kapodistrian University of Athens, Athens 12464, Greece.
Eleni Panopoulou2 nd Department of Pathology, University General Hospital "ATTIKON", School of Medicine, National and Kapodistrian University of Athens, Athens 12464, Greece.
Vasileia Damaskou2 nd Department of Pathology, University General Hospital "ATTIKON", School of Medicine, National and Kapodistrian University of Athens, Athens 12464, Greece.
Vasileios Sioulas3 rd Department of Gynaecology and Obstetrics, University General Hospital "ATTIKON", School of Medicine, National and Kapodistrian University of Athens, Athens 12464, Greece.
Charalambos Chrelias3 rd Department of Gynaecology and Obstetrics, University General Hospital "ATTIKON", School of Medicine, National and Kapodistrian University of Athens, Athens 12464, Greece.
Sofia Kalantaridou3 rd Department of Gynaecology and Obstetrics, University General Hospital "ATTIKON", School of Medicine, National and Kapodistrian University of Athens, Athens 12464, Greece.
Ioannis G Panayiotides2 nd Department of Pathology, University General Hospital "ATTIKON", School of Medicine, National and Kapodistrian University of Athens, Athens 12464, Greece.
National and Kapodistrian University of Athens · GRUniversity General Hospital Attikon · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

E6E7HPV16methylationUTR

Identifiers

PMID31528222
PMCPMC6746133
OpenAlexW2968657393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.